Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns

Jonathan Ricka Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Alyssa M. Thompsonb College of Medicine, University of Arizona, Tucson, AZ, USA

Jennifer L. Hsiaoc Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, CA, USA

Wilson Liaod Department of Dermatology, University of California San Francisco, San Francisco, CA, USA

Vivian Y. Shia Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USACorrespondence[email protected]

https://orcid.org/0000-0002-7510-9428

Click to increase image sizeClick to decrease image size

Disclosure statement

JLH has served as an advisor for Novartis. WL has received research grant funding from Abbvie, Amgen, Janssen, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi, and TRex Bio. VYS is a stock shareholder of Learn Health, and has served as an advisor, investigator and/or speaker for Sanofi Genzyme, Regeneron, AbbVie, Burt’s Bees, Dermira, Eli Lilly, Novartis, Pfizer, Galderma, Leo Pharma, SUN Pharma, Menlo Therapeutics, GpSkin, and Skin Actives Scientific.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns

Information for

Open access

Opportunities

Help and information

Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature